Breadcrumb
NIH Guide: Weekly Index for November 1, 2024
Weekly NIH Funding Opportunities and Notices
November 1, 2024
Policy Notices
-
AHRQs Implementation of HHS 2 CFR Part 200 Transition and the Grants Policy Statement Update Effective October 1, 2024
(NOT-HS-25-007)Agency for Healthcare Research and Quality
-
Announcement of Childcare Costs for Predoctoral to Postdoctoral Fellow Transition Programs F99 Recipients
(NOT-OD-25-008)National Institutes of HealthNational Institute on AgingNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Human Genome Research InstituteNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and Bioengineering
General Notices
-
Notice to Clarify Instructions for NIDA's Career Development Award Salary Limits
(NOT-DA-24-053)National Institute on Drug Abuse
-
NIGMS Interest in Technology Development for Cryo-Electron Tomography
(NOT-GM-25-002)National Institute of General Medical Sciences
-
Notice of Informational Webinar for NIGMS Award Recipients: Understanding the Basics of the NIGMS Research Performance Progress Report (RPPR)
(NOT-GM-25-006)National Institute of General Medical Sciences
-
Solicitation of Nominations for the 2024 National Human Genome Research Institutes Bettie J. Graham Leadership Award
(NOT-HG-25-008)National Human Genome Research Institute
-
Notice of Informational Webinar: Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional; R61/R33 Clinical Trial Required)
(NOT-TW-24-011)John E. Fogarty International Center
-
Request for Information (RFI): Researching COVID to Enhance Recovery Treating Long COVID (RECOVER-TLC)
(NOT-AI-25-007)National Institute of Allergy and Infectious Diseases
-
Request for Information (RFI): Inviting Comments and Suggestions on the NIH Minority Health and Health Disparities Strategic Plan, 2026-2030
(NOT-MD-25-002)National Institute on Minority Health and Health Disparities
Notice of Changes to Funding Opportunities
-
Notice of Participation of the National Institute on Aging in RFA-NR-25-001, "Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional)"
(NOT-AG-24-069)National Institute on Aging
-
Notice of Change for RFA-DA-25-056, Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed)
(NOT-DA-25-034)National Institute on Drug Abuse
-
Notice of Change to Institutional Eligibility Criteria in PAR-24-041 "Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)"
(NOT-GM-25-004)National Institute of General Medical Sciences
-
Notice of Early Expiration of PAR-22-268, "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)"
(NOT-HG-25-010)National Human Genome Research Institute
-
Notice of NHLBI Participation in RFA-HD-25-003 "Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)"
(NOT-HL-24-025)National Heart, Lung, and Blood Institute
-
Notice of Change to Award Budget for SBIR/STTR Commercialization Readiness Pilot Program (CRP)
(NOT-OD-25-014)Office of the Director, NIH
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Diversity in Aging Research (ADAR) through Undergraduate Education Coordinating Center (U24 Clinical Trial Not Allowed)
(NOT-AG-24-070)National Institute on Aging
-
Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
(NOT-DA-24-049)National Institute on Drug Abuse
-
Notice of Intent to Publish a Funding Opportunity Announcement for Annual Conference in Therapeutics Development for Substance Use Disorders (U13 Clinical Trial Not Allowed)
(NOT-DA-25-033)National Institute on Drug Abuse
-
Notice of Intent to Publish a Funding Opportunity Announcement for NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
(NOT-DC-25-006)National Institute on Deafness and Other Communication Disorders
-
Notice of Intent to Publish a Funding Opportunity Announcement for Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
(NOT-HG-25-011)National Human Genome Research Institute
-
Notice of Intent to Publish a Funding Opportunity for Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein NRSA Individual Postdoctoral Fellowship (F32)
(NOT-OD-25-006)Office of the Director, NIH
-
Notice of Intent to Publish a Funding Opportunity for Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
(NOT-OD-25-007)Office of the Director, NIH
-
Notice of Intent to Publish a Funding Opportunity Announcement for In Vivo Non-Invasive Optical Approaches for Biological systems (UG3/HU3 Clinical Trial Not Allowed)
(NOT-RM-24-014)Office of Strategic Coordination (Common Fund)
Notices of Special Interest
-
Notice of Special Interest (NOSI): Establishing and Utilizing Pre-Clinical Animal Models to Study Post-TB Lung Disease Development
(NOT-AI-24-082)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control
(NOT-CA-25-004)National Cancer Institute
-
Notice of Special Interest (NOSI): Administrative Supplements to Support Extramural Collaborators for Notified Applicants for the Bench-to-Bedside and Back Program (BtB) (Clinical Trial Optional)
(NOT-OD-24-180)Office of the Director, NIH
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows
(NOT-OD-25-009)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's Health
Funding Opportunities
-
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
(PAR-24-264)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsNational Institute of General Medical SciencesNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
(PAR-24-265)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsNational Institute on AgingNational Institute of General Medical SciencesNational Eye InstituteNational Institute of Mental HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
(PAR-24-268)National Institute of General Medical SciencesNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
(PAR-24-312)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
(PAR-24-313)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
(PAR-24-326)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsNational Institute of General Medical SciencesApplication Receipt Date(s): Multiple dates, see announcement.
-
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
(PAR-25-024)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
(PAR-25-053)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
(PAR-25-077)National Institute of Neurological Disorders and StrokeNational Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
(PAR-25-118)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
(PAR-25-119)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
(PAR-25-122)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesNational Institute of Allergy and Infectious DiseasesNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
(PAR-25-131)National Library of MedicineApplication Receipt Date(s): Multiple dates, see announcement.
-
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
(PAR-25-143)National Cancer InstituteNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
(PAR-25-144)National Cancer InstituteNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
(PAR-25-149)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
(PAR-25-185)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Dental and Craniofacial ResearchDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
-
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
(PAR-25-206)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
(PAR-25-207)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
(PAR-25-210)National Center for Complementary and Integrative HealthNational Institute on AgingNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
(PAR-25-211)National Center for Complementary and Integrative HealthNational Institute on AgingNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
(PAR-25-233)National Cancer InstituteNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeJohn E. Fogarty International CenterOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionApplication Receipt Date(s): Multiple dates, see announcement.
-
Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional)
(RFA-AG-25-027)National Institute on AgingApplication Receipt Date(s): January 10, 2025
-
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
(RFA-DA-25-068)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
(RFA-DA-25-069)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
(RFA-MH-25-205)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
(RFA-MH-25-206)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
(RFA-NS-25-019)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): October 17, 2025
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: December 4, 2024
For technical issues E-mail OER Webmaster